SOUTH SAINT PAUL, MN – (July 15, 2020) – Veterinary Hospitals Association (VHA), the leading association for veterinary practices in the Midwest, has signed a partnership deal with Heska, a leading provider of advanced veterinary diagnostic and specialty products.
As part of this agreement, VHA members who have signed an agreement will have access to place any Heska order conveniently through VHA.
"Heska is dedicated to providing VHA members the very latest in lab diagnostics," explained VHA Executive Director Jeff Benson. "This dedication supports our members in their ultimate goal of providing the very best veterinary care for their patients and clients."
“We are excited to work with VHA and its member clinics! We have become more familiar with VHA’s diverse membership so are confident that Heska’s scalable solution is a perfect fit,” states Kevin Klass, Heska Vice President of Sales. “The agreement will provide VHA members the industry’s fastest-growing, most innovative diagnostic line at significant operational savings.”
VHA members who would like to learn more about this partnership and to sign an agreement are encouraged to contact their Veterinary Practice Consultant.
About Veterinary Hospitals Association
Veterinary Hospitals Association (VHA) was established in 1984 and is a not-for-profit association dedicated to supporting veterinary professionals and practices by offering solutions that enable them to grow, learn, and succeed. VHA currently serves over 420 member veterinary practices in Minnesota, Wisconsin, and North Dakota. Learn more by visiting www.veterinaryha.org or follow VHA on Facebook, Instagram, Twitter, and LinkedIn.
Heska Corporation (NASDAQ: HSKA) manufactures, develops and sells advanced veterinary diagnostic and specialty healthcare products through its two business segments: Core Companion Animal Health ("CCA") and Other Vaccines and Pharmaceuticals ("OVP"). CCA segment includes Point of Care Laboratory testing instruments and consumables, primarily under a unique multi-year subscription model, digital imaging products, software and services, data services, allergy testing, and immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. OVP segment includes private label vaccine and pharmaceutical production under third party agreements and channels, primarily for herd animal health.
To learn more about Heska, visit www.heska.com.